Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma

Breaking resistance to chemotherapy is a major goal of combination therapy in many tumors, including advanced neuroblastoma. We recently demonstrated that increased activity of the PI3K/Akt network is associated with poor prognosis, thus providing an ideal target for chemosensitization. Here we show...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Westhoff, Mike-Andrew, Faham, Najmeh, Marx, Daniela, Nonnenmacher, Lisa, Jennewein, Claudia, Enzenmüller, Stefanie, Gonzalez, Patrick, Fulda, Simone, Debatin, Klaus-Michael
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2013
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3877010/
https://ncbi.nlm.nih.gov/pubmed/24391739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0083128
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires